Morgan Stanley analyst Jonathan Chung downgraded Lanxess to Equal Weight from Overweight with a price target of EUR 30, down from EUR 35. The analyst says delays in the cycle recovery pose further downside risks to earnings and the company’s leverage in the short term.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LNXSF:
